Related Experiment Video

Updated: Aug 11, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Rheumatoid arthritis: developing pharmacological therapies

Richard J Misischia, Larry W Moreland

    Expert Opinion on Investigational Drugs
    |June 27, 2002
    PubMed

    Insights

    Newer rheumatoid arthritis (RA) treatments, including COX-2 inhibitors and anti-TNF agents, offer improved efficacy and safety. Further research into pathways like angiogenesis inhibition promises even better therapeutic outcomes for RA patients.

    Area of Science:

    • Immunology
    • Rheumatology
    • Pharmacology

    Background:

    • Rheumatoid arthritis (RA) is a chronic inflammatory condition causing significant disability and mortality.
    • Current RA therapies, while beneficial, are often suboptimal and the disease etiology is unknown.
    • Recent therapeutic advancements have begun to shift the treatment landscape for RA.

    Purpose of the Study:

    • To review the impact of recent therapeutic advancements in rheumatoid arthritis (RA).
    • To highlight the effectiveness and safety profiles of novel RA treatment agents.
    • To explore potential future therapeutic targets for RA, such as angiogenesis inhibition.

    Main Methods:

    • Review of recent literature on rheumatoid arthritis (RA) therapies.
    • Analysis of the efficacy and side effect profiles of new RA treatment agents.
    • Discussion of emerging research into novel therapeutic pathways for RA.

    Main Results:

    • Newer agents like COX-2 inhibitors, anti-TNF agents, and interleukin-1 antagonists have improved RA treatment effectiveness.
    • These advanced therapies offer improved outcomes with a relatively low risk of adverse effects.
    • Investigating pathways such as angiogenesis inhibition shows promise for future RA treatments.

    Conclusions:

    • Recent therapeutic innovations have significantly improved the management of rheumatoid arthritis (RA).
    • Targeting novel pathways, including angiogenesis, holds potential for developing superior RA therapeutics.
    • A deeper understanding of the immune system's role in RA enhances opportunities for improved treatments.

    More Related Videos

    An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

    An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

    Published on: June 6, 2025

    Related Concept Videos

    The JAK-STAT Signaling Pathway01:20

    The JAK-STAT Signaling Pathway

    Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

    Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
    Inflammatory Bowel Disease IV: Pharmacological Management01:29

    Inflammatory Bowel Disease IV: Pharmacological Management

    Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
    Pharmacologic...
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...